Literature DB >> 2439101

Rheumatoid factor and immune networks.

D A Carson, P P Chen, R I Fox, T J Kipps, F Jirik, R D Goldfien, G Silverman, V Radoux, S Fong.   

Abstract

Rheumatoid factors represent a normal component of the immune network. The autoantibodies promote complement fixation and clearance of immune complexes. They amplify the avidity of polyclonally induced IgG. Genes related to the primary structure of rheumatoid-factor light chains are widely distributed in the human population and have been conserved during the evolution and dispersion of the species. Products of these genes may be detected with anti-idiotypic antibodies against synthetic peptides corresponding to individual hypervariable regions on rheumatoid-factor light chains. Such anti-peptide antibodies provide unique reagents for analyzing the genetics of immunoglobulins in outbred populations. Precursors of rheumatoid factor are abundant among immature B lymphocytes. Some of these cells may tend to localize to mucosal surfaces, where they are stimulated directly by pathogenic microorganisms with polyclonal B cell-activating properties. Synthesis of rheumatoid factor regularly accompanies all secondary immune responses but is usually transient. Production of the autoantibody is T-cell dependent. The T cells may recognize antigen in an IgG-antigen immune complex that is processed and presented by B-cell precursors of rheumatoid factor. Rheumatoid factor-associated light-chain idiotypes are rare in serum IgG and on IgG myeloma proteins. They are common among monoclonal IgM proteins and on the surface of the malignant B cells from patients with chronic lymphatic leukemia. The rheumatoid factors that are produced by patients with mixed cryoglobulinemia, or primary Sjogren's syndrome can share idiotypic antigens with monoclonal rheumatoid factors. Rheumatoid factor synthesis in the diseases may reflect an abnormal proliferation of B-cells that is not antigen-driven and that can degenerate into malignancy. The rheumatoid factors in patients with rheumatoid arthritis are diverse and almost certainly represent the outcome of antigen-induced, T cell-dependent mechanisms. The antigens that drive the T cells have not been identified but could represent exogenous microorganisms, self components, or idiotypic antigens that fortuitously interact with rheumatoid factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439101     DOI: 10.1146/annurev.iy.05.040187.000545

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  45 in total

Review 1.  Properties of polyreactive natural antibodies to self and foreign antigens.

Authors:  T Logtenberg
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

Review 2.  New roles for rheumatoid factor.

Authors:  D A Carson; P P Chen; T J Kipps
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

3.  Rheumatoid factors: where are we now?

Authors:  A I Soltys; J S Axford; B J Sutton
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

Review 4.  T lymphocytes in synovia of patients with rheumatoid arthritis.

Authors:  I Stamenkovic; M Stegagno; S M Krane; J T Kurnick
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

Authors:  S P Moyes; R N Maini; R A Mageed
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.

Authors:  L Mantovani; R L Wilder; P Casali
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

7.  Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus.

Authors:  D F Huang; K A Siminovitch; X Y Liu; T Olee; N J Olsen; C Berry; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated.

Authors:  K Youngblood; L Fruchter; G Ding; J Lopez; V Bonagura; A Davidson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.

Authors:  R P MacDermott; S Schreiber; G S Nash; W J Koopman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

Review 10.  Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.

Authors:  Y W Song; E H Kang
Journal:  QJM       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.